Strides Pharma Science Limited FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · May 20, 2026
  • Last warning letter 2019
Inspections 13 1 OAI
Recalls 1 0 Class I (0%)
Warning letters 1 Latest Jul 1, 2019
510(k) clearances 0 None on file

Strides Pharma Science Limited has 1 FDA recall, 13 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Strides Pharma Science Limited, the most recent on Jul 1, 2019. FDA has published 1 Form 483 for Strides Pharma Science Limited.

What these totals cover: FDA records filed under the name "Strides Pharma Science Limited". Records filed under related names are not included; see Related names.

Latest recall
D-0079-2027 · Oct 7, 2026 · filed under Strides Pharma
Latest recall under this name
D-1029-2020 · Class III · Feb 17, 2020
Latest inspection
May 20, 2026 · VAI

Newer recall under related name Strides Pharma: Oct 7, 2026, D-0079-2027.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls1Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections13Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Strides Pharma Science Limited's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Strides Pharma Science Limited: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 2 inspections (1 OAI), 1 warning letter, 0 recall records (0 Class I) 2020: 2 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202610000
202500000
202400000
202310000
202210000
202100000
202020010
201921100
201810000
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Strides Pharma Science Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Strides Pharma Science Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Strides Pharma Science Limited FDA Warning Letters

1 warning letter on Jul 1, 2019.

IssuedSubjectIssuing officeClose-out letter
Jul 1, 2019 · Letter on fda.gov Center for Drug Evaluation and Research

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Strides Pharma Science Limited Form 483s

1 Form 483 published by FDA.

DateDocumentFEI
May 20, 2026 · Document on fda.gov 4833004554612

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

1 recall record on Feb 17, 2020.

NumberClassProductDate
D-1029-2020Class IIIPotassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only…Feb 17, 2020

Recent FDA inspections

13 inspections from Jul 22, 2011 to May 20, 2026.

DateSiteProductClassificationFEI
May 20, 2026Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
Feb 24, 2023Puducherry, IndiaDrugsVoluntary Action Indicated (VAI)3012448465
Dec 9, 2022Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
Mar 5, 2020Bangalore, IndiaDrugsNo Action Indicated (NAI)3004554612
Jan 17, 2020Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
May 24, 2019Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
Feb 5, 2019Puducherry, IndiaDrugsOfficial Action Indicated (OAI)3012448465
Nov 2, 2018Bangalore, IndiaDrugsNo Action Indicated (NAI)3004554612
May 26, 2017Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
Feb 19, 2016Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
Aug 26, 2014Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
Dec 20, 2013Bangalore, IndiaDrugsNo Action Indicated (NAI)3004554612
Jul 22, 2011Bangalore, IndiaDrugsNo Action Indicated (NAI)3004554612
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Strides Pharma Science Limited: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Jul 1, 2019.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

2 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3004554612Bangalore, India11May 20, 2026
FEI 3012448465Puducherry, India2Feb 24, 2023

Strides Pharma Science Limited and the FDA: common questions

Has Strides Pharma Science Limited received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Strides Pharma Science Limited. The most recent is dated Jul 1, 2019.

Has Strides Pharma Science Limited received an FDA Form 483?

FDA has published 1 Form 483 for Strides Pharma Science Limited in its reading room, the most recent dated May 20, 2026. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Strides Pharma Science Limited?

The most recent FDA inspection on file ended May 20, 2026 at Bangalore, India and was classified VAI. FDA has 13 inspections of Strides Pharma Science Limited on file, 1 of them classified OAI (official action indicated).

Has Strides Pharma Science Limited had an FDA recall?

Yes. Strides Pharma Science Limited has 1 FDA recall on record. The most recent under this name started Feb 17, 2020. A newer recall, dated Oct 7, 2026, is filed under the related name Strides Pharma.

Need more than this page shows? Ask about Strides Pharma Science Limited in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.